PlainRecalls
FDA Drug Low Class III Terminated

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10

Reported: October 28, 2020 Initiated: October 9, 2020 #D-0044-2021

Product Description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10

Reason for Recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Details

Recalling Firm
ANI Pharmaceuticals, Inc.
Units Affected
13536 bottles
Distribution
Distributed Nationwide in the USA
Location
Baudette, MN

Frequently Asked Questions

What product was recalled?
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10. Recalled by ANI Pharmaceuticals, Inc.. Units affected: 13536 bottles.
Why was this product recalled?
Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 28, 2020. Severity: Low. Recall number: D-0044-2021.